Preterm Premature Rupture of Membrane Clinical Trial
Official title:
Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation: a Double-blinded Randomized Controlled Trial
The purpose of this study is to assess whether short-term (48 hr) tocolysis reduces perinatal morti-morbidity in cases of PPROM at 22 to 33 completed weeks' gestation.
Preterm premature rupture of membranes (PPROM) complicates 3% of pregnancies and accounts for one-third of preterm births. It is a leading cause of neonatal mortality and morbidity and increases the risk of maternal infectious morbidity. In cases of early PPROM (22 to 33 completed weeks' gestation), expectant management is recommended in the absence of labor, chorioamnionitis or fetal distress. Antenatal steroids and antibiotics administration are recommended by international guidelines. However, there is no recommendation regarding tocolysis administration in the setting of PPROM. In theory, reducing uterine contractility should delay delivery and reduce risks of prematurity and neonatal adverse consequences. Likewise, a prolongation of gestation may allow administering a corticosteroids complete course that is associated with a two-fold reduction of morbidity and mortality. However, tocolysis may prolong fetal exposure to inflammation and be associated with higher risk of materno-fetal infection, potentially associated with neonatal death or long-term sequelae, including cerebral palsy. The purpose of this study is to assess whether short-term (48 hr) tocolysis reduces perinatal morti-morbidity in cases of PPROM at 22 to 33 completed weeks' gestation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04963465 -
The Accuracy of Amniotic Fluid Ferning in the Second Trimester in the Diagnosis of Preterm Prelabor Rupture of Membranes
|
||
| Recruiting |
NCT03992534 -
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
|
Phase 1 | |
| Completed |
NCT04294069 -
Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial
|
Phase 4 | |
| Completed |
NCT01503606 -
Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane
|
Phase 3 | |
| Recruiting |
NCT04590677 -
Prediction of the Onset of Term and Preterm Labour
|
||
| Recruiting |
NCT04110704 -
Cerclage After Full Dilatation Caesarean Section
|
N/A | |
| Completed |
NCT03473210 -
The Value of Amniopatch in Preterm Premature Rupture of Membranes
|
N/A | |
| Not yet recruiting |
NCT05328817 -
Azithromycin Versus Erythromycin For Preterm Prelabor Rupture of Membranes
|
N/A | |
| Recruiting |
NCT05353153 -
The Psychological Experience of Pathological Pregnancy. Study of the Case of Premature Rupture of Membranes and Evaluation of the Impact of Hypnosis Support
|
N/A | |
| Completed |
NCT03814278 -
Bed Rest After Preterm Premature Rupture of the Membranes
|
N/A | |
| Completed |
NCT04807543 -
Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes
|
Phase 2 | |
| Not yet recruiting |
NCT05207800 -
Predictive Value of Maternal Serum Pentraxin 3 (PTX 3) and Heparin-binding Protein (HBP) for Chorioamnionitis in Preterm Premature Rupture of Membranes
|
||
| Recruiting |
NCT04705935 -
Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth
|
||
| Active, not recruiting |
NCT06074601 -
MIRACLE of LIFE Study
|
||
| Recruiting |
NCT04516226 -
Vaginal Cleansing With Chlorhexidine Gluconate in Women With Preterm Pre-labor Rupture of Membranes
|
N/A | |
| Recruiting |
NCT03306719 -
mtDNA as Novel Biomarker for Intra-amniotic Infection
|
N/A | |
| Completed |
NCT04413019 -
Domiciliary Versus Hospital Management of PPROM
|